Antivenin: Difference between revisions
(Creation of page) |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 68: | Line 68: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] [[Category:Toxicology]] | ||
Latest revision as of 20:13, 19 September 2019
Administration
- Type: Antivenom
- Dosage Forms: IM, IV
- Routes of Administration: IM/IV
- Common Trade Names: Antivenin
Adult Dosing
- Black widow spider bite
- 2.5 mL IM/IV x1
- Give skin or conjunctival test before use
- May repeat dose x1
- Prefer IV for severe cases
- 2.5 mL IM/IV x1
Pediatric Dosing
- Black widow spider bite
- <12 yo
- 2.5 mL IM/IV x1
- Give skin or conjunctival test before use
- May repeat dose x1
- 2.5 mL IM/IV x1
- >12 yo
- 2.5 mL IM/IV x1
- Give skin or conjunctival test before use
- May repeat dose x1
- Prefer IV for severe cases
- 2.5 mL IM/IV x1
- <12 yo
Special Populations
- Pregnancy Rating: C; Benefits outweight risks during pregnancy
- Lactation risk: L3; Safety unknown
Renal Dosing
- Adult: Not defined
- Pediatric: Not defined
Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
- Caution if hypersensitivity to horse serum
- Caution if asthma
Adverse Reactions
Serious
Common
- Injection site pain
- Hypersensitivity reaction
- Muscle cramps
Pharmacology
- Half-life: <15 days
- Metabolism: Unknown
- Excretion: Unknown
Mechanism of Action
- A equine serum globulin that binds to toxins
